Physician profile
Andrew E Barker
NPI 1346803855
$9,420.84
in general payments reported to CMS, 2019-2025
22 companies · $4,611 in 2025
The $4,611 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $192 · 2023: $1,527 · 2024: $3,090 · 2025: $4,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,758 · Travel and Lodging: $3,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,758.33 |
| Travel and Lodging | $3,470.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,793.79 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, Spyglass Discover |
| Saluda Medical Americas, INC. | $2,759.82 | 2024-2025 | Evoke |
| Spinal Simplicity, LLC | $1,015.00 | 2024-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $903.84 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Avanos Medical | $451.50 | 2022-2024 | Generator, Standard Rf Disposables |
| Nevro Corp. | $422.14 | 2024 | Senza |
| Stryker Corporation | $174.47 | 2024 | Spinejack |
| Painteq LLC | $166.10 | 2023 | Painteq |
| Averitas Pharma INC. | $122.10 | 2024 | Qutenza |
| Biotronik Nro, INC. | $104.81 | 2025 | Prospera |
| Pfizer INC. | $95.42 | 2025 | |
| Globus Medical, INC. | $87.30 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $73.77 | 2025 | |
| Collegium Pharmaceutical, INC. | $59.48 | 2025 | Belbuca |
| Abbvie INC. | $46.74 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $34.80 | 2024-2025 | Movantik |
| Fidia Pharma USA INC. | $26.01 | 2025 | Hymovis, Triluron |
| Axsome Therapeutics, INC. | $23.43 | 2025 | Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.46 | 2025 | Relistor |
| Azurity Pharmaceuticals, INC. | $15.11 | 2025 | Horizant |
| Advanced Oxygen Therapy INC. | $14.29 | 2024 | Topical Oxygen Chamber For Extremities |
| Hydrocision, INC. | $13.46 | 2025 | Tenjet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.